Precise Application Of Echogenic Needles In Chronic Neuralgia Pain Management

https://www.nature.com/articles/s41598-024-72620-8

1. Clinical Pain Points

Chronic neuralgia including postherpetic neuralgia, limb residual neuralgia and superficial branch neuralgia is a common intractable pain disease, requiring long-term precise nerve block intervention. Traditional treatment methods have obvious defects: long-term oral analgesic drugs cause systemic side effects such as liver and kidney damage and drug dependence, with poor targeted treatment effect. Ordinary puncture needles used for nerve block have low positioning accuracy, unable to accurately lock tiny lesion nerve branches covered by scar tissues and inflammatory adhesions. Single ultrasound guidance cannot distinguish lesion nerves from surrounding fibrous hyperplasia tissues, resulting in inaccurate drug injection position, short analgesia duration and high pain recurrence rate. Repeated ineffective treatment not only increases patients' physical pain and economic burden, but also delays the optimal treatment period of chronic neuralgia, leading to intractable persistent pain.

2. Product Working Principle

Echogenic Needle for Nerve Block realizes precise targeted treatment of chronic neuralgia through dual high-precision positioning technology. The ultra-fine laser echo enhancement structure on the stainless steel needle surface can present ultra-clear micro-imaging under high-frequency ultrasound, accurately identifying tiny lesion nerve branches and distinguishing them from scar adhesion and inflammatory hyperplasia tissues, realizing precise visual positioning of micro-pain lesions. The high-sensitivity electrical nerve stimulation system can induce weak bioelectrical responses of tiny lesion nerves. Clinicians can accurately judge the activity and specific position of pain-causing nerves by adjusting low-intensity stimulation current, realizing precise locking of lesion points. The dual verification mode of ultrasound micro-imaging and nerve electrical feedback eliminates tissue interference, ensures the needle tip accurately targets the lesion nerve area, and realizes targeted drug delivery to block pain signal transmission.

3. Product Specification Classification and Pain Scenario Matching

Aiming at the micro-precision treatment characteristics of chronic neuralgia, echogenic needles adopt ultra-fine high-precision specification design. The 24G-26G ultra-fine models are the core specifications for chronic neuralgia treatment, with ultra-thin needle body, minimal tissue trauma, no damage to normal nerve and soft tissues, suitable for repeated long-term minimally invasive treatment. The 22G micro-enhanced specifications have stronger echo penetration, suitable for deep residual neuralgia and inflammatory neuralgia treatment. All products are made of high-purity medical stainless steel, with super smooth electropolishing surface, reducing tissue adhesion during repeated puncture. After professional sterilization treatment, they meet the safety standards of repeated clinical intervention. Products support customized sizes and packaging, adapting to individualized pain treatment needs of different patients.

4. Standard Pain Intervention Operation Guidelines

Before chronic neuralgia intervention, combine the patient's pain location, disease course and imaging results to locate the lesion nerve range, and select 24G-26G ultra-fine echogenic needles. Use high-frequency high-resolution ultrasound probe to scan the pain area in detail, distinguish lesion nerve branches from scar and adhesive tissues. Adopt micro-invasive slow in-plane puncture technique, advance the ultra-fine needle at a uniform slow speed to avoid nerve compression damage. Observe the needle tip micro-trajectory in real time through ultrasound high-definition echo images, turn on the low-intensity nerve stimulation mode, and fine-tune the needle position until weak targeted nerve response appears. After confirming accurate lesion positioning and negative blood aspiration, inject low-concentration long-acting analgesic and neurotrophic drugs in micro-dosage batches, observe uniform drug infiltration around the lesion nerve, and complete the precise block treatment.

5. Practical Clinical Treatment Experience

Long-term pain management clinical data shows that echogenic needle precise nerve block has excellent curative effect on chronic neuralgia. Compared with ordinary needle treatment, the accurate targeting rate of lesion nerves is increased by 60%, the one-time treatment effective rate rises from 65% to 93%, and the pain recurrence rate is reduced by more than 65%. The ultra-fine minimally invasive design avoids secondary damage to normal tissues and nerves, with low postoperative adverse reaction rate and high patient comfort. For intractable neuralgia ineffective in conventional drug treatment, dual-mode precise positioning can accurately lock hidden lesion nerves, effectively block pain signal conduction, and significantly prolong the analgesia cycle. Long-term follow-up shows that standardized echogenic needle intervention can significantly improve patients' pain symptoms, improve sleep quality and daily living ability, and reduce dependence on oral analgesics.

6. Summary and Technical Sublimation

The core difficulty of chronic neuralgia treatment lies in the accurate positioning of tiny lesion nerves covered by scar and inflammatory tissues and targeted drug delivery. Traditional treatment methods have defects such as large systemic side effects, low positioning accuracy and easy recurrence. Echogenic nerve block needles rely on ultra-fine minimally invasive design and dual high-precision positioning technology to break through the technical bottleneck of intractable chronic pain treatment. It realizes minimally invasive, accurate and long-acting pain intervention, reduces unnecessary repeated treatment and patient burden, and provides a new standardized and precise treatment scheme for chronic neuralgia in pain medicine.

7. Future Industry Development Suggestions

With the continuous improvement of public demand for chronic pain quality management, precise minimally invasive intervention has become the mainstream development direction of pain medicine. It is suggested that specialized pain departments comprehensively promote the application of ultra-fine echogenic nerve block needles and formulate individualized treatment schemes for different types of chronic neuralgia. Manufacturers should further optimize the micro-laser echo process of ultra-fine needles to improve the recognition ability of ultra-tiny nerve branches. Carry out multi-center clinical research to summarize the optimal puncture parameters and drug dosage for chronic pain intervention. At the same time, strengthen the technical combination of echogenic needle block and nerve rehabilitation therapy to further improve the long-term cure rate of intractable chronic neuralgia.